Structural basis of DNA-dependent coactivator recruitment by the tuft cell master regulator POU2F3
Year: 2025
Type: article
Abstract: The transcription factor POU2F3 defines the identity of tuft cells and underlies a distinct molecular subtype of small cell lung cancer (SCLC). Although POU2F3 is considered undruggable, its activity critically depends on the coactivators OCA-T1 and OCA-T2. Here, we demonstrate that acute suppression of either POU2F3 or OCA-T1 induces regression of tuft cell-like SCLC xenografts in vivo. To explore the structural basis and druggability of this dependency, we determine crystal structures of POU2F3 bound to OCA-T1 or OCA-T2 in complex with DNA, revealing a tripartite, DNA-dependent interface. We further employ deep mutational scanning to assess the functional impact of 4,218 missense variants in POU2F3 and OCA-T1, uncovering both mutation-sensitive hotspots and structurally constrained regions critical for tumor cell fitness. These findings define a transcriptional complex that integrates DNA recognition with coactivator recruitment and nominate POU2F3-OCA-T as a structurally tractable vulnerability in tuft cell-like carcinomas.
Source: Cell Reports
Authors: Aktan Alpsoy, Jonathan J. Ipsaro, Damianos Skopelitis, Sujay Pal, Frank S. Chung, Shannon Carpenter, John J. Desmarais, Xiaoli S. Wu, Kenneth Chang, Matthew T. DiMare, Erin Harten, Staci Bergman, Justin B. Kinney, Jeffrey A. Engelman, Hyo-Eun C. Bhang, Leemor Joshua-Tor, Christopher R. Vakoc
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,620
Awards: ADVANCING LINEAGE-DIRECTED THERAPY AS PERSONALIZED MEDICINE FOR SMALL CELL LUNG CANCER, Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer, G7721780970, Biophysical modeling of cis-regulatory complexes in transcription and splicing using massively parallel reporter assays, G9000229355, Targeting Transcription and Splicing in Cancer, A unified quantitative modeling strategy for multiplex assays of variant effect, Biology and vulnerabilities of POU2F3+ tuft cell-like carcinomas, Genetic technology development for elucidating lineage plasticity mechanisms in cancer, CSHL Cancer Center Support Grant
OpenAlex ID: W4416328432
